Approval · Notice of Compliance 2794 · 1998
CIPRO: Notice of Compliance 2794
Issued March 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2794
- Date
- March 6, 1998
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRO | 02237513 | — |
| CIPRO | 02237514 | Marketed |
Medicinal ingredients
- CIPROFLOXACIN 5 G per 100ML
- CIPROFLOXACIN 10 G per 100ML